Inhaled melatonin for sleep problems in older adults
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new inhaled form of melatonin to help adults aged 55 and older with insomnia fall asleep faster. It compares the inhaled melatonin to a placebo to see if it improves sleep and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years or older.
- You have had trouble falling asleep, staying asleep, or waking too early for at least 3 months, and it happens at least 3 nights per week.
- Your sleep difficulties affect how you feel or function during the day.
- You are able to read and understand English.
- You are not regularly using sleep aids, certain antidepressants, stimulants, or other interfering medications for at least 2 weeks before starting the trial.
- You do not have untreated sleep apnea, a serious mental health condition, or certain other medical issues that might make the trial unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a melatonin supplement to a type of talk therapy for insomnia (called CBT-I) helps older adults sleep better. It aims to improve sleep quality and reduce insomnia symptoms.
This study tests a special sleep program to help older adults who have trouble falling asleep or staying asleep. It uses software and may improve your sleep without new medications.
This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.
This study tests if melatonin, a low dose of quetiapine, or a placebo can help people with a psychiatric condition who also have trouble sleeping. You may qualify if you have insomnia at least 3 times a week and your sleep problem has lasted 3 months or longer.
This trial studies whether timed light exposure can help people who have trouble falling asleep. It aims to improve insomnia symptoms by testing a light-based approach while carefully measuring sleep patterns.
This study looks at how a brain chemical called norepinephrine affects sleep and thinking in older adults with insomnia. You may join if you are 55+, have insomnia, and are generally healthy.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.